Freeline Therapeutics Holdings plc is a gene therapy company focused on developing treatments for rare genetic diseases. With a proprietary platform technology and a team of experts, the company is dedicated to bringing innovative therapies to patients in need. Their American Depositary Shares are listed on the Nasdaq exchange.
